Travere Therapeutics Inc (TVTX)
Operating Cash Flow Growth
1065.38%
Quarterly · Period ending:

TVTX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported1065.38%period ending
Latest reported1065.38%period ending
TVTX Quarterly Cash from Operations YoY % (-33.86% → 1065.38%)
Year-over-year change
High-resolution chart · PNG
TVTX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 1,065.3823% | |
| 4.3324% | |
| 269.8712% | |
| 133.6815% | |
| 112.3823% | |
| 64.5443% | |
| 49.3139% | |
| 28.1175% | |
| 41.9268% | |
| -46.7078% | |
| -28.9769% | |
| -49.6116% | |
| -88.2764% | |
| -46.6323% | |
| -103.2965% | |
| -223.2729% | |
| -666.5948% | |
| -108.9597% | |
| -93.7779% | |
| 376.0653% | |
| 200.6664% | |
| 9.1957% | |
| -208.7711% | |
| 147.6949% | |
| 66.2306% | |
| -42.275% | |
| -26.0028% | |
| -262.1698% | |
| -592.3551% | |
| -39.0797% | |
| -317.4473% | |
| -169.1435% | |
| -151.168% | |
| -430.7637% | |
| 87.3725% | |
| 18.8659% | |
| 35.188% | |
| 22.1755% | |
| -165.3197% | |
| 231.9804% | |
| -49.49% | |
| 51.3598% | |
| 71.9719% | |
| 109.2194% | |
| 168.9924% | |
| 25.2123% | |
| -11.6332% | |
| -483.6998% | |
| -418.4625% | |
| -114.1639% | |
| 99.7023% | |
| -463.4857% | |
| -24,537,655.5556% | |
| -25,436,677.7778% | |
| -15,204,105,405.5556% | |
| -1,884,924% | |
| 62.5% | |
| 103.1034% | |
| 80.2198% | |
| 99.2003% | |
| -33.3333% | |
| -107.3464% | |
| 99.6017% | |
| -33.8566% |